Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Effect of Controlled Microtopography on Osteogenic Differentiation of Mesenchymal Stem Cells

Chen C., Zhu Y., Wang R., Han Y., Zhou H.

Narrative Review on Hip, published in J Healthc Eng (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Healthc Eng (2022)
Reported sample size
—
Source database
Europe PMC
PMID
35126944
PMCID
PMC8816539
DOI
10.1155/2022/7179723
Citations
10

Abstract (original English)

Various kinds of controlled microtopographies can promote osteogenic differentiation of mesenchymal stem cells (MSCs), such as microgrooves, micropillars, and micropits. However, the optimal shape, size, and mechanism remain unclear. In this review, we summarize the relationship between the parameters of different microtopographies and the behavior of MSCs. Then, we try to reveal the potential mechanism between them. The results showed that the microgrooves with a width of 4-60 μ m and ridge width μ m, micropillars with parameters less than 10 μ m, and square micropits had the full potential to promote osteogenic differentiation of MSCs, while the micromorphology of the same size could induce larger focal adhesions (FAs), well-organized cytoskeleton, and superior cell areas. Therefore, such events are possibly mediated by microtopography-induced mechanotransduction pathways.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Mesenchymal Stem CellsHumansMechanotransduction, CellularCell DifferentiationOsteogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research